Targeting IL-18BP to Boost Immunity. Graphical Abstract ©ArnaudHUARD/UNIGE. SUMMARY. Interleukin (IL)-18 is an immunoregulatory cytokine that acts as a potent inducer of T helper ...
Mucormycosis or ‘black fungus’, is a fungal infection affecting the sinuses, lungs, brain, and skin. The fungal infection is ...
Presented preclinical non-human primate (NHP) data at the 20th Congress of European Crohn's and Colitis Organization in Inflammatory Bowel Diseases 2025 (ECCO) for SL-325, a potentially first-in-class ...
- Presented preclinical non-human primate (NHP) data at the 20th Congress of European Crohn's and Colitis Organization in Inflammatory Bowel Diseases 2025 (ECCO) for SL-325, a potentially ...
From April 25 to 30, 2025, the American Association for Cancer Research (AACR) Annual Meeting will take place in Chicago. CStone will showcase its latest preclinical studies on five internally ...
Leveragen Inc., a Boston-based biotechnology company specializing in next-generation genetic models for antibody discovery, ...
Bispecific antibodies (BsAbs) have emerged as a transformative class of biologics, offering dual-targeting mechanisms that enhance therapeutic efficacy across oncology, autoimmune disorders, and ra | ...
ProMIS Neurosciences (PMN) announced plans to deliver virtual oral presentations at the 2025 Alzheimer’s and Parkison’s Disease International ...
H5N1 influenza is evolving rapidly, weakening the effectiveness of existing antibodies and increasing its potential threat to ...
The H5N1 avian influenza virus is mutating to evade immune defenses in mammals following prior infection or vaccination.
A vaccine's ability to generate long-lasting, high-affinity antibodies hinges on a delicate balance. Upon exposure to a vaccine or pathogen, B cells scramble to refine their defenses, rapidly mutating ...
The H5N1 influenza virus poses a significant threat to public health due to its potential to shift from an epidemic to a pandemic. Since its emergence in the 1990s, H5N1 has demonstrated a concerning ...